Welcome to CDC Stacks | Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. Centers for Disease Control and Prevention - 7375 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. Centers for Disease Control and Prevention
Filetype[PDF - 339.54 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
    Personal Author:
    Mofenson, Lynne M.
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.), Public Health Service Task Force.; National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention--Surveillance and Epidemiology.; United States, Public Health Service., Perinatal HIV Guidelines Working Group.;
    Published:
    November 22, 2002
    Series:
    Morbidity and mortality weekly report. Recommendations and reports ; v. 51, no. RR-18
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 51, no. RR-18
    Description:
    "These recommendations update the February 4,2002, guidelines developed by the Public Health Service for the use of zidovudine (ZDV) to reduce the risk for perinatal human immunodeficiency virus type 1 (HIV-1) transmission. This report provides healt...
    File Type:
    Filetype[PDF - 520.38 KB]
  2. U.S. Public Health Service Task Force recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States
    Corporate Author:
    Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, USA.
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2002; 51(RR-18):1-38; quiz CE1-4.
    Description:
    These guidelines replace CDC's 1994 guidelines, HIV Counseling, Testing, and Referral Standards and Guidelines, and contain recommendations for public- and private-sector policy makers and service providers of human immunodeficiency virus (HIV) couns...
    Status:
    superseded
    File Type:
    Filetype[PDF - 520.38 KB]
  3. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
    Corporate Author:
    Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
    Status:
    current
    File Type:
    Filetype[PDF - 155.10 MB]
  4. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents
    Corporate Author:
    Panel on Clinical Practices for the Treatment of HIV Infection (U.S.); Centers for Disease Control and Prevention (U.S.); National Institutes of Health (U.S.). Office of AIDS Research. Advisory Council.;
    Published:
    April 8, 2015
    Description:
    Antiretroviral therapy (ART) for the treatment of HIV infection has improved steadily since the advent of potent combination therapy in 1996. New drugs that offer new mechanisms of action, improvements in potency and activity even against multidrug-r...
    Status:
    current
    File Type:
    Filetype[PDF - 4.11 MB]
  5. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
    Status:
    superseded
    File Type:
    Filetype[PDF - 158.45 MB]